J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 532, Number 3, 685-700, May 1, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, L. A.
Right arrow Articles by Alger, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, L. A.
Right arrow Articles by Alger, B. E.
Journal of Physiology (2001), 532.3, pp. 685-700
© Copyright 2001 The Physiological Society

Heterogeneous susceptibility of GABAA receptor-mediated IPSCs to depolarization-induced suppression of inhibition in rat hippocampus


L. A. Martin, D.-S. Wei and B. E. Alger


Department of Physiology, University of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, MD 21201, USA

  1. Depolarization-induced suppression of inhibition (DSI) in central neurons is mediated by a transient reduction of gamma-aminobutyric acid (GABA) release from interneurons. DSI is induced by a retrograde signal emitted from principal cells. We used electrophysiological recordings from CA1 neurons of the rat hippocampal slice to test the hypothesis that only certain classes of interneurons are susceptible to DSI.
  2. DSI of action potential-dependent, spontaneous, inhibitory postsynaptic currents (sIPSCs) in hippocampus is facilitated by carbachol (3 µM), which increases the occurrence of large sIPSCs. Besides carbachol, noradrenaline (norepinephrine; 10 µM), or elevated extracellular potassium (8 mM), could abruptly increase the occurrence of large sIPSCs and DSI in many cases. DSI appeared and disappeared concomitantly with the onset and offset of these large sIPSCs. In contrast, application of AP-5 and CNQX often markedly increased baseline sIPSC activity without enhancing DSI.
  3. A brief train of extracellular electrical stimulation could trigger the onset of prolonged, repetitive IPSC activity that was susceptible to DSI. The magnitude of DSI of single evoked IPSCs (eIPSCs) in a given pyramidal cell could be altered by changes in stimulus strength, but there was no simple relationship between stimulus strength and DSI.
  4. Baclofen (0.5-5 µM) eliminated the increase in sIPSC activity and DSI induced by carbachol. A GABAB receptor antagonist, CGP 35348, reversed the effects of baclofen.
  5. Carbachol-induced sIPSCs had relatively rapid rise and decay phases. There was no marked distinction between DSI-susceptible and non-susceptible sIPSCs. Nevertheless, two kinetically distinct components of the eIPSC could be distinguished by their decay times. DSI reduced GABAA,fast without affecting GABAA,slow. Furosemide (frusemide), which blocks only GABAA,fast, reduced the eIPSC and occluded DSI.
  6. The data suggest that, with respect to DSI, there are at least three functionally distinct types of IPSCs. Two types (one susceptible to DSI and one not) have relatively rapid kinetics are probably made by perisomatic synapses. A third, slow IPSC, which is insensitive to DSI, may be produced by distal dendritic synapses.



This article has been cited by other articles:


Home page
Cereb CortexHome page
M. Galarreta, F. Erdelyi, G. Szabo, and S. Hestrin
Cannabinoid Sensitivity and Synaptic Properties of 2 GABAergic Networks in the Neocortex
Cereb Cortex, January 17, 2008; (2008) bhm253v1.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. K. Makara, I. Katona, G. Nyiri, B. Nemeth, C. Ledent, M. Watanabe, J. de Vente, T. F. Freund, and N. Hajos
Involvement of Nitric Oxide in Depolarization-Induced Suppression of Inhibition in Hippocampal Pyramidal Cells during Activation of Cholinergic Receptors
J. Neurosci., September 19, 2007; 27(38): 10211 - 10222.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Chen, A. Neu, A. L. Howard, C. Foldy, J. Echegoyen, L. Hilgenberg, M. Smith, K. Mackie, and I. Soltesz
Prevention of Plasticity of Endocannabinoid Signaling Inhibits Persistent Limbic Hyperexcitability Caused by Developmental Seizures
J. Neurosci., January 3, 2007; 27(1): 46 - 58.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. E. Hofmann, B. Nahir, and C. J. Frazier
Endocannabinoid-Mediated Depolarization-Induced Suppression of Inhibition in Hilar Mossy Cells of the Rat Dentate Gyrus
J Neurophysiol, November 1, 2006; 96(5): 2501 - 2512.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Isokawa and B. E. Alger
Ryanodine Receptor Regulates Endogenous Cannabinoid Mobilization in the Hippocampus
J Neurophysiol, May 1, 2006; 95(5): 3001 - 3011.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
C. G. Reich, M. A. Karson, S. V. Karnup, L. M. Jones, and B. E. Alger
Regulation of IPSP Theta Rhythm by Muscarinic Receptors and Endocannabinoids in Hippocampus
J Neurophysiol, December 1, 2005; 94(6): 4290 - 4299.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. Trettel, D. A. Fortin, and E. S. Levine
Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex
J. Physiol., April 1, 2004; 556(1): 95 - 107.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. F. FREUND, I. KATONA, and D. PIOMELLI
Role of Endogenous Cannabinoids in Synaptic Signaling
Physiol Rev, July 1, 2003; 83(3): 1017 - 1066.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Kim, M. Isokawa, C. Ledent, and B. E. Alger
Activation of Muscarinic Acetylcholine Receptors Enhances the Release of Endogenous Cannabinoids in the Hippocampus
J. Neurosci., December 1, 2002; 22(23): 10182 - 10191.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Ohno-Shosaku, H. Tsubokawa, I. Mizushima, N. Yoneda, A. Zimmer, and M. Kano
Presynaptic Cannabinoid Sensitivity Is a Major Determinant of Depolarization-Induced Retrograde Suppression at Hippocampal Synapses
J. Neurosci., May 15, 2002; 22(10): 3864 - 3872.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R. I. Wilson and R. A. Nicoll
Endocannabinoid Signaling in the Brain
Science, April 26, 2002; 296(5568): 678 - 682.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Varma, G. C. Carlson, C. Ledent, and B. E. Alger
Metabotropic Glutamate Receptors Drive the Endocannabinoid System in Hippocampus
J. Neurosci., December 15, 2001; 21(24): RC188 - RC188.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 The Physiological Society.